Los Angeles Capital Management LLC Instil Bio, Inc. Transaction History

Los Angeles Capital Management LLC

  • $27.9 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$4.21 - $11.15 $178,756 - $473,429
-42,460 Closed
0 $0
Q1 2022

May 06, 2022
BUY
$8.48 - $18.1 $360,060 - $768,526
42,460 New
42,460 $456,000

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $8.8B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email